当前位置:首页 - 行情中心 - 精华制药(002349) - 财务分析 - 现金流量表

精华制药

(002349)

  

流通市值:60.58亿  总市值:61.73亿
流通股本:8.14亿   总股本:8.30亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,090,553,738.46712,736,551.48356,259,418.751,391,635,115.64
  收到的税费返还140,411.5136,020.36655.75211,319.03
  收到其他与经营活动有关的现金34,800,496.1422,814,198.869,715,305.9160,650,347.47
  经营活动现金流入小计1,125,494,646.11735,586,770.7365,975,380.411,452,496,782.14
  购买商品、接受劳务支付的现金374,113,694.97244,518,755.38117,998,241.56472,276,173.88
  支付给职工以及为职工支付的现金262,339,809.71182,775,435.3198,809,298.56315,654,346.93
  支付的各项税费125,589,604.5783,426,414.4939,741,180.37156,757,094.33
  支付其他与经营活动有关的现金138,891,836.797,179,832.4847,825,407.2196,790,717.76
  经营活动现金流出小计900,934,945.95607,900,437.66304,374,127.691,141,478,332.9
  经营活动产生的现金流量净额224,559,700.16127,686,333.0461,601,252.72311,018,449.24
二、投资活动产生的现金流量:
  收回投资收到的现金878,000,000681,000,000275,000,000885,473,316.1
  取得投资收益收到的现金3,244,899.392,188,021.2484,220.229,476,081.76
  处置固定资产、无形资产和其他长期资产收回的现金净额31,00031,00031,000115,200
  收到的其他与投资活动有关的现金10,618,402.78--46,217,212.44
  投资活动现金流入小计891,894,302.17683,219,021.2275,515,220.22941,281,810.3
  购建固定资产、无形资产和其他长期资产支付的现金13,639,408.369,017,610.455,414,710.6430,922,944.63
  投资支付的现金1,233,700,000865,700,000357,000,000665,000,000
  支付其他与投资活动有关的现金121,051,082.31121,000,000-351,167,825.16
  投资活动现金流出小计1,368,390,490.67995,717,610.45362,414,710.641,047,090,769.79
  投资活动产生的现金流量净额-476,496,188.5-312,498,589.25-86,899,490.42-105,808,959.49
三、筹资活动产生的现金流量:
  吸收投资收到的现金56,708,04056,708,040--
  取得借款收到的现金200,000--10,000,000
  收到其他与筹资活动有关的现金8,2968,296-678,724.78
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计56,916,33656,716,336-10,678,724.78
  偿还债务支付的现金10,000,00010,000,000-20,900,000
  分配股利、利润或偿付利息支付的现金84,948,612.984,948,612.956,75096,456,382.48
  其中:子公司支付给少数股东的股利、利润---20,911,040
  支付其他与筹资活动有关的现金662,935.69573,685.69413,209.981,343,921.52
  筹资活动现金流出小计95,611,548.5995,522,298.59469,959.98118,700,304
  筹资活动产生的现金流量净额-38,695,212.59-38,805,962.59-469,959.98-108,021,579.22
四、汇率变动对现金及现金等价物的影响-1,402,722.56-432,880.12-48,758.592,133,396.08
五、现金及现金等价物净增加额-292,034,423.49-224,051,098.92-25,816,956.2799,321,306.61
  加:期初现金及现金等价物余额1,013,520,736.471,013,520,736.471,013,520,736.47914,199,429.86
  期末现金及现金等价物余额721,486,312.98789,469,637.55987,703,780.21,013,520,736.47
补充资料:
  净利润-151,686,598.43-247,466,264.86
  资产减值准备-4,927,023.94-18,661,687.38
  固定资产和投资性房地产折旧-37,645,326.04-72,994,590.18
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-37,645,326.04-72,994,590.18
  无形资产摊销-1,072,945.74-2,144,147.94
  处置固定资产、无形资产和其他长期资产的损失--28,384.68-202,291.53
  固定资产报废损失---1,035,789.55
  公允价值变动损失--1,451,220.5--3,816,186.27
  财务费用--2,881,097.39--6,474,816.65
  投资损失--1,434,037.28--4,372,311.26
  递延所得税-334,193.16--570,035.7
  其中:递延所得税资产减少--23,703.23-241,954.72
    递延所得税负债增加-357,896.39--811,990.42
  存货的减少--12,659,133.76-6,434,179.92
  经营性应收项目的减少--55,089,953.71--11,167,434.72
  经营性应付项目的增加-5,016,187.49--17,323,500.07
  其他---4,437,662.96
  融资租入固定资产---729,396.39
  现金的期末余额-789,469,637.55-1,013,520,736.47
  减:现金的期初余额-1,013,520,736.47-914,199,429.86
  现金及现金等价物的净增加额--224,051,098.92-99,321,306.61
公告日期2025-10-302025-08-302025-04-302025-04-15
审计意见(境内)标准无保留意见
TOP↑